Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.66 USD | -3.89% | -1.16% | -38.37% |
May. 09 | Piper Sandler Adjusts Price Target on Paragon 28 to $15 From $18, Maintains Overweight Rating | MT |
May. 08 | Transcript : Paragon 28, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart calendar Paragon 28, Inc.
Upcoming events on Paragon 28, Inc.
Past events on Paragon 28, Inc.
2024-05-17 11:00 am | Annual General Meeting |
2024-05-14 | BofA Securities Health Care Conference |
2024-05-08 04:30 pm | Q1 2024 Earnings Call |
2024-05-08 04:05 pm | Q1 2024 Earnings Release |
2024-02-29 04:30 pm | Q4 2023 Earnings Call |
2024-02-29 04:05 pm | Q4 2023 Earnings Release |
2024-02-12 04:00 pm | Canaccord Genuity Musculoskeletal Conference |
2024-01-08 06:00 pm | JPMorgan Healthcare Conference |
2023-11-28 04:30 pm | Piper Sandler Healthcare Conference |
2023-11-15 05:00 pm | Stephens Investment Conference |
2023-11-07 04:30 pm | Q3 2023 Earnings Call |
2023-11-07 04:05 pm | Q3 2023 Earnings Release |
2023-09-11 04:45 pm | Morgan Stanley Global Healthcare Conference |
2023-08-09 08:30 am | Canaccord Genuity Growth Conference |
2023-08-02 04:30 pm | Q2 2023 Earnings Call |
2023-08-02 04:05 pm | Q2 2023 Earnings Release |
2023-05-17 11:00 am | Annual General Meeting |
2023-05-10 05:20 pm | Bank of America Healthcare Conference |
2023-05-04 04:30 pm | Q1 2023 Earnings Call |
2023-05-04 04:05 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 147 146 0.91% | 181 180 0.49% | 216 216 0.04% | 256 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 3,11 -0,39 906.74% | -10,7 -10,9 1.77% | -9,72 -3,80 -155.76% | -8,84 |
EBIT Million USD | Released Forecast Spread | 0,00 | -10,8 -11,0 1.78% | -62,0 -32,8 -89.33% | -37,3 -31,7 -17.62% | -39,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -13,0 -12,7 -2.2% | -67,4 -35,7 -88.86% | -47,6 -34,8 -36.96% | -48,6 |
Net income Million USD | Released Forecast Spread | 3,50 | -13,7 -13,0 -5.38% | -67,3 -36,0 -87.08% | -47,8 -35,1 -36.14% | -48,5 |
EPS USD | Released Forecast Spread | 0,22 | -0,26 -0,33 21.21% | -0,88 -0,47 -87.23% | -0,58 -0,44 -33.12% | -0,58 |
Announcement Date | 24/09/21 | 08/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 41,4 37,5 10.42% | 42,5 40,3 5.51% | 46,0 42,5 8.29% | 51,5 50,6 1.74% | 52,0 50,1 3.9% | 51,0 50,1 1.8% | 52,8 52,1 1.33% | 60,6 60,5 0.05% | 61,1 60,3 1.36% | 60,1 | 63,0 | 71,6 | 71,8 | 71,3 |
EBITDA Million USD | Released Forecast Spread | -3,30 -0,58 -468.02% | -3,17 -0,64 -394.07% | -2,72 -5,11 46.77% | -1,48 -1,65 10.22% | -1,42 -1,67 15.01% | -2,63 -1,80 -46.35% | -1,25 -1,69 25.89% | -4,42 1,50 -395.18% | -5,48 -1,83 -199.07% | -3,89 | -1,78 | 2,23 | 0,28 | 0,38 |
EBIT Million USD | Released Forecast Spread | -8,44 -4,63 -82.06% | -9,08 -4,71 -92.88% | -8,49 -8,86 4.15% | -36,0 -6,77 -432.43% | -7,74 -7,11 -8.9% | -9,36 -7,45 -25.58% | -8,98 -7,59 -18.36% | -11,2 -5,66 -98.52% | -12,9 -8,49 -51.9% | -11,4 | -9,34 | -5,61 | -6,93 | -7,53 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,20 -5,08 -81.07% | -9,53 -5,73 -66.23% | -9,52 -9,12 -4.38% | -39,1 -7,40 -428.77% | -9,12 -8,19 -11.44% | -10,6 -8,53 -24.57% | -8,44 -8,76 3.63% | -19,4 -7,03 -176.67% | -15,0 -10,7 -39.93% | -14,1 | -11,8 | -8,16 | -10,2 | -10,4 |
Net income Million USD | Released Forecast Spread | -9,24 -4,79 -92.66% | -9,60 -5,70 -68.54% | -9,72 -8,96 -8.49% | -38,8 -7,41 -423.18% | -9,05 -8,20 -10.45% | -10,9 -8,41 -29.52% | -8,33 -8,48 1.78% | -19,6 -7,20 -171.78% | -15,2 -10,7 -42.71% | -13,8 | -11,7 | -8,18 | -9,55 | -10,4 |
EPS USD | Released Forecast Spread | -0,12 -0,07 -71.43% | -0,13 -0,07 -79.31% | -0,13 -0,12 -10.64% | -0,51 -0,10 -427.57% | -0,11 -0,10 -7.84% | -0,13 -0,10 -27.86% | -0,10 -0,10 3.61% | -0,23 -0,09 -151.56% | -0,18 -0,12 -45.95% | -0,17 | -0,14 | -0,10 | -0,12 | -0,13 |
Announcement Date | 09/05/22 | 03/08/22 | 10/11/22 | 02/03/23 | 04/05/23 | 02/08/23 | 07/11/23 | 29/02/24 | 08/05/24 | - | - | - | - | - |
2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
2024-05-24 08:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
2024-05-28 05:00 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
2024-06-18 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
2024-06-26 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
2024-07-03 | MANI, INC.: Q3 2024 Earnings Release (Projected) |
2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
2024-07-11 | ARJO AB: Q2 2024 Earnings Release |
2024-07-12 01:30 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
Past sector events for Paragon 28, Inc.
2024-05-17 04:19 am | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | HOYA CORPORATION: Q4 2023 Earnings Release |
2024-05-14 01:00 am | AMBU A/S: Q2 2024 Earnings Release |
2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | TERUMO CORPORATION: Q4 2024 Earnings Release |
2024-05-13 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
2024-05-12 | PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
2024-05-10 04:10 pm | ATRION CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FNA Stock
- Calendar Paragon 28, Inc.